Moolec Science SA - Ordinary shares (MLEC)

Moolec Science (NASDAQ:MLEC) secures USDA approval for revolutionary plant-grown animal proteins, sending shares soaring.

SolarEdge layoffs are a hot topic on Monday as the solar energy company announces plans to cut 400 jobs on weak European demand.

Moolec Science stock is down on Monday even as MLEC investors learn of a new agreement with a global consumer packaged goods company.

It's time to start the trading week with a breakdown of the biggest pre-market stock movers worth reading about on Monday!

MLEC stock results show that Moolec Science beat analyst estimates for earnings per share the third quarter of 2024.

Hepion Pharmaceuticals stock is falling on Monday as investors in HEPA learn of the company winding down a Phase 2b clinical trial.

Vaxxinity stock is falling hard on Monday after the company announced plans to voluntarily delist shares of VAXX stock next month.

OLB Group stock is rising higher on Monday alongside heavy trading of the company's shares despite a lack of news this morning.

Moolec Science stock is taking off on Monday with heavy trading of MLEC shares following approval for its genetically engineered soybean.

It's time to start ofd the trading week with a look at the biggest pre-market stock movers traders need to watch on Monday morning!

Friday is here and we're breaking down the biggest pre-market stock movers that traders need to know about this morning!

Companies Reporting Before The Bell • Sangamo Therapeutics (NASDAQ:SGMO) is likely to report quarterly loss at $0.26 per share on revenue of $8.10 million.